Just launched · October 2026—Rankings get sharper with every edition.Spotted an error?Tell us →
Sign in / Register
Food & agriculture
Global segment ranking · Food & agriculture › Agriculture

The world’s most valuable biological inputs startups

Edition 0·Published 9 Oct 2026·Next scheduled update 12 Feb 2027

Companies that make biological and bio-based inputs for crops: microbial fertilisers and biostimulants, biopesticides and biofungicides (microbes, peptides, RNA, proteins), pheromones and other natural signals for pest control, and beneficial insects. Ranked worldwide by AI-estimated valuation, with listed pure players shown in grey at their market value for reference. The market sets the value; our AI estimates it.

Twice a year Claude · multi-AI consensus from 1 Dec 2026· Method· Order never changed by a human

Key metrics for this segment: key milestone. Figures as published by each company or the press, dated, not recalculated. The AIs weigh them alongside funding history and comparables.

Not in this segment. Listed, so not ranked: Biotalys (shown in grey), Bioceres Crop Solutions and Vittia, whose biologicals sit beside other crop inputs, Amoéba, Eden Research, Save Foods and Bee Vectoring. Bought by a group: Symborg (Corteva), BioPhero (FMC), Biotrop (BioFirst), Ceradis (Gowan), Plant Health Care (PI Industries), Marrone Bio (Bioceres), AgBiome (assets sold). Created by a group or owned by a family without outside investors: Koppert, Andermatt, Agrauxine (Lesaffre), Lavie Bio (Evogene), Suterra, Rizobacter, IPL Biologicals, ENAI (launched by Indigo Ag). Closed: Joyn Bio. In other segments: soil carbon programmes (Indigo Ag, Loam Bio) under Carbon credits, soil analytics and sensors (Biome Makers, Trace Genomics, Pattern Ag, Semios) under Precision farming; crop-protection chemistry discovered with AI (Enko, Moa Technology), plant genetics (Cibus, Ohalo), animal health and multi-industry fermentation (Locus Fermentation Solutions) are outside this segment. Chinese companies (Moon Biotech) are never ranked. A company appears in one segment only. Method

The segment at a glance
32companies ranked
12companies on the radar
10countries in the ranking
3listed benchmarks
Sources: Company announcements, AgFunder News, Global AgInvesting, AgNavigator, AgFeed, Business Wire, CFNews, Tech.eu, The Packer, Fertilizer Daily, company filings and market data for listed companies. Intention counters will be shown above a threshold of amount and number of Backers.

Rankings by region

Filter the ranking and the Radar. Ranks stay worldwide. Regional pages: Asia · Europe · Latin America & Caribbean · Middle East & North Africa · North America.

Global ranking · Biological inputs

First edition: no movements yet.

World · 32 ranked companies

#CompanyLast round · Key metricsEstimated valuation (AI) · rangePool of interestsInterest: a free, non-binding declaration on a company, or on a sector within an area, made during the free phase of a pool.

Pool: all the Interests declared on the same target. This column shows the number of Backers and the combined amount of their tickets.
Terms for Backers →
BackBacking a startup on Uback (pronounced “you back”) can be done in two ways:

Interest · free: a non-binding declaration that signals your demand for a company or a sector. You can move or withdraw it at any time, with up to 5 at once.

Intention · coming soon: a paid, confirmed declaration, still non-binding. Once its pool reaches critical mass, it is presented to a company by a local partner.

Neither is an order nor a commitment to invest.
Terms for Backers →
1 BioFirstBelgium · Europe · Controlled by Floridienne Capital increase · USD 428M · Sep 2023Acquired 85% of Brazil's Biotrop (2023 sales ~EUR 125M) · Dec 2023 Last known equity round: Capital increase · USD 428M · Sep 2023 (Sofina, Tikehau Capital, M&G, Unigrains, Sofiprotéol); about EUR 400M, financing the purchase of BiotropMethod — Back
2 Pivot BioUnited States · North America Series D · USD 430M · Jul 2021Revenue passed USD 100M in 2023 · 2023 Last known equity round: Series D · USD 430M · Jul 2021 (DCVC, Temasek; Breakthrough Energy Ventures, Bill & Melinda Gates Foundation)Method — Back
3 Sound AgricultureUnited States · North America Series D · USD 100M · Dec 2024Products used on about 2 million US acres · Dec 2024 Last known equity round: Series D · USD 100M · Dec 2024 (BMO Impact Investment Fund, S2G Ventures); USD 75M in 2022 plus a USD 25M extensionMethod — Back
4 VestaronUnited States · North America Series C · USD 92M · Aug 2022Spear peptide products (Spear-T, Spear-Lep) registered and sold in the US · Aug 2022 Last known equity round: Series C · USD 92M · Aug 2022 (Ordway Selections, Cavallo Ventures; Novo Holdings, Syngenta Ventures, Fortistar); USD 82M plus a USD 10M extensionMethod — Back
5 Invaio SciencesUnited States · North America · Controlled by Flagship Pioneering (creator and lead investor) Series C · USD 88.9M · May 2021Partnership with Brazil's Fundecitrus against citrus greening · Jan 2026 Last known equity round: Series C · USD 88.9M · May 2021 (Flagship Pioneering; Stage 1 Ventures, Bluwave Capital, Alexandria Venture Investments)Method — Back
6 Aphea.BioBelgium · Europe Series C · USD 77M · Jul 2023First biostimulant seed treatment ΛCTIV launched commercially in Europe · Jul 2023 Last known equity round: Series C · USD 77M · Jul 2023 (Innovation Industries; Korys, Bill & Melinda Gates Foundation, SFPIM, ECBF, Astanor); EUR 70MMethod — Back
7 SuperbacBrazil · Latin America & Caribbean Private equity (minority) · USD 62.5M · Jul 2023Key metrics not disclosed Last known equity round: Private equity (minority) · USD 62.5M · Jul 2023 (XP Private Equity); BRL 300M for about 30%Method — Back
8 Elicit PlantFrance · Europe Series B · USD 47.7M · Nov 2024Biostimulants applied on more than 500,000 hectares of crops · Nov 2024 Last known equity round: Series B · USD 47.7M · Nov 2024 (Carbyne Equity Partners; Sofinnova Partners, ECBF, Bpifrance (Ecotechnologies 2)); EUR 45MMethod — Back
9 NewLeaf SymbioticsUnited States · North America Series D · USD 45M · Dec 2023Products used on about 3.5 million acres in 2023 · Dec 2023 Last known equity round: Series D · USD 45M · Dec 2023 (Gullspang Re:food; Otter Capital, S2G Ventures, Leaps by Bayer)Method — Back
10 MicropepFrance · Europe Series B · USD 40M · Sep 2024Collaborations with R&D, manufacturing and distribution partners incl. Corteva · Sep 2024 Last known equity round: Series B · USD 40M · Sep 2024 (Corteva Catalyst, Sparkfood; existing investors); USD 29M plus an USD 11M extensionMethod — Back
11 AgroSpheresUnited States · North America Series B · USD 37M · Sep 2024EPA approval of first AgriCell-powered biofungicide · Sep 2024 Last known equity round: Series B · USD 37M · Sep 2024 (Zebra Impact Ventures; Lewis and Clark AgriFood, Ospraie Ag Science, FMC Ventures, BIDRA, Cavallo)Method — Back
12 AgrivalleBrazil · Latin America & Caribbean · Controlled by 10b Growth equity · USD 30.8M · Jul 20202025 sales volume up 25%; 2026 revenue growth guided at 10-15% · Mar 2026 Last known equity round: Growth equity · USD 30.8M · Jul 2020 (Tarpon); BRL 160MMethod — Back
13 GreenLight BiosciencesUnited States · North America · Controlled by a consortium led by Fall Line Capital Series C · USD 25M · Mar 2025Calantha RNA spray registered in the US and Ukraine for potato growers · Apr 2025 Last known equity round: Series C · USD 25M · Mar 2025 (Just Climate)Method — Back
— BiotalysBelgium · Listed · Euronext Brussels · BTLS Product revenue none in H1 2026Private placement EUR 12.05M from existing investors, May 2026 about USD 105MMarket cap · Oct 2026Listed company · not ranked
14 SolubioBrazil · Latin America & Caribbean · Controlled by Aqua Capital Growth equity · USD 19.8M · Apr 2024BRL 206M revenue in 2023; targets BRL 1bn within five years · Apr 2024 Last known equity round: Growth equity · USD 19.8M · Apr 2024 (Aqua Capital); BRL 100M, partly buying out former partnersMethod — Back
15 MycophytoFrance · Europe Series A · USD 18.7M · Jan 2026Expanding to Spain and Morocco, new markets Côte d'Ivoire and Benelux · Jan 2026 Last known equity round: Series A · USD 18.7M · Jan 2026 (Innovacom, BNP Paribas, Bpifrance Deep Tech 2030; CDG Invest, Noshaq, RSI, Crédit Agricole); EUR 16MMethod — Back
16 AgriodorFrance · Europe Series A · USD 17.1M · Apr 2026First sugar beet aphid product distributed under exclusive deal with Syngenta · Apr 2026 Last known equity round: Series A · USD 17.1M · Apr 2026 (Crédit Mutuel Impact; Région Sud Investissement, Capagro, SWEN Capital Partners); EUR 15MMethod — Back
17 Pluton BiosciencesUnited States · North America Series A · USD 16.5M · May 2023Key metrics not disclosed Last known equity round: Series A · USD 16.5M · May 2023 (Illumina Ventures, RA Capital; Fall Line Capital, Grantham Foundation)Method — Back
18 BioConsortiaUnited States · North America · Controlled by Otter Capital and affiliated funds (lead, long-standing investors) Financing round · USD 15M · Aug 2025Always-N nitrogen seed treatment launched in New Zealand in 2024; Mosaic partner for Americas · Aug 2025 Last known equity round: Financing round · USD 15M · Aug 2025 (Otter Capital and affiliated funds); existing investors; split between equity and debt not statedMethod — Back
19 Solasta BioUnited Kingdom · Europe Series A · USD 14M · Sep 20242023 field trials performed as well as or better than standard insecticides (company) · 2023 Last known equity round: Series A · USD 14M · Sep 2024 (Forbion, FMC Ventures, Corteva Catalyst; Cavallo Ventures, Scottish Enterprise); GBP 10.7MMethod — Back
20 FytekoBelgium · Europe Series B · USD 13.5M · Feb 2025Biostimulants sold to major seed and plant-nutrition companies since 2022 · Feb 2025 Last known equity round: Series B · USD 13.5M · Feb 2025 (Crédit Mutuel Impact; SFPIM, Supernova Invest, IMBC, finance&invest.brussels, existing shareholders); EUR 13MMethod — Back
21 GenicaBrazil · Latin America & Caribbean Series C · USD 12.5M · Jun 20242025 revenue above BRL 200M (+~30%); 2026 budget BRL 300M · Jan 2026 Last known equity round: Series C · USD 12.5M · Jun 2024 (Mitsubishi Corporation (lead); SP Ventures, Vox Capital); BRL 68MMethod — Back
22 Ascribe BioUnited States · North America Series A · USD 12M · Oct 2025First regulatory approval of Phytalix biofungicide expected in Brazil · Oct 2025 Last known equity round: Series A · USD 12M · Oct 2025 (Acre Venture Partners, Corteva Catalyst; Syngenta Group Ventures, Trailhead Capital)Method — Back
23 Toopi OrganicsFrance · Europe Series A · USD 11.8M · Sep 2023Lactopi Start authorised for sale in six EU countries · 2022 Last known equity round: Series A · USD 11.8M · Sep 2023 (VisVires New Protein; Edaphon, MAIF Impact, BNP Paribas Développement); EUR 11M equity at ~1.07 USD/EUR (Sept 2023); total EUR 16M incl. ~EUR 5M non-dilutive excludedMethod — Back
24 Groundwork BioAgIsrael · Middle East & North Africa Funding round · USD 11M · May 2021Inoculants used on about 1 million acres · 2021 Last known equity round: Funding round · USD 11M · May 2021 (Ibex Investors; ProDelta, Future Foodways)Method — Back
25 Harpe Bioherbicide SolutionsUnited States · North America Funding round · USD 10.5M · Apr 2023Key metrics not disclosed Last known equity round: Funding round · USD 10.5M · Apr 2023 (ADM; iSelect, Alexandria Venture Investments)Method — Back
26 Sea6 EnergyIndia · Asia Series B · USD 9M · Jul 2021Key metrics not disclosed Last known equity round: Series B · USD 9M · Jul 2021 (Aqua-Spark (lead); Silverstrand Capital); USD 9M as reported.Method — Back
27 ArevoSweden · Europe Series A · USD 8.5M · Oct 2025Launched bio-based lawn fertiliser; moving to industrial-scale production · Oct 2025 Last known equity round: Series A · USD 8.5M · Oct 2025 (Industrifonden, Fort Knox, Navigare Ventures, Stora Enso); EUR 7.3MMethod — Back
28 FA BioUnited Kingdom · Europe Funding round · USD 6.7M · Feb 2024Key metrics not disclosed Last known equity round: Funding round · USD 6.7M · Feb 2024 (Clean Growth Fund, Pymwymic; Ship2B Ventures); GBP 5.3MMethod — Back
29 BioPrime AgriSolutionsIndia · Asia Series A · USD 6M · Oct 2024BioNexus platform identified 170+ novel strains from a library of ~18,000 · Oct 2024 Last known equity round: Series A · USD 6M · Oct 2024 (Edaphon (lead); Omnivore, Inflexor Ventures); USD 6M as reported.Method — Back
30 Immunrise BiocontrolFrance · Europe Funding round · USD 5.1M · Aug 2022Key metrics not disclosed Last known equity round: Funding round · USD 5.1M · Aug 2022 (Baron Philippe de Rothschild group, De Sangosse); EUR 5MMethod — Back
31 Evologic TechnologiesAustria · Europe Funding round · USD 3M · Feb 2021Fermentation plant in Vienna serving international customers · Feb 2021 Last known equity round: Funding round · USD 3M · Feb 2021 (ASKUR Invest; RWA, BayWa, Mauthner, Vivida); EUR 2.5MMethod — Back
32 WAKUJapan · Asia Pre-Series A · USD 2.2M · Aug 2026Key metrics not disclosed Last known equity round: Pre-Series A · USD 2.2M · Aug 2026 (Chugin Capital Partners, Asahi Media Lab Ventures, Nanto Capital Partners, Tottori Capital); JPY 330M; bank loans not countedMethod — Back

Back · Declaring an intention does not mean this company is raising funds. · Terms

Corporate investor? Back the startups of your own segment

Ranking in descending order of AI-estimated valuation, based on public information, with no human intervention on the order. The valuations, ranges and brackets shown are editorial estimates produced by AI, purely indicative and imperfect by nature: neither a financial valuation, nor an offer, nor investment advice. Only the market sets a company’s value, through a funding round or a sale. Ranking established by Claude (Anthropic) from public information, following the published rules. A consensus of several AIs will apply from 1 December 2026. Eligibility: at least $1M raised in equity, non-listed company, main activity in this segment (biological inputs). Country shown is the country of main operations. Request a correction

How to read this ranking

Rank

Companies are ranked by AI-estimated valuation, highest first. The market sets the value; our AI estimates it.

Estimate

An AI-estimated valuation, its uncertainty range and its order of magnitude. Indicative, and imperfect by nature.

  1. Hundreds of k$
  2. Millions $
  3. Tens of M$
  4. Hundreds of M$
  5. Unicorn
  6. Decacorn
  7. Hectocorn

Full method →

Challengers

A registered company raising funds that is not in the ranking will be able, for a fee, to appear in a separate list labelled “Challengers”, for a set period, with a memo available to verified Backers. The listing has no effect on the ranking. Not open yet.

Sponsored space · no Challenger listed yet

Radar · known eligible companies, not ranked

Sorted by date of last round, with no judgement and no AI call.

Chinese companies · for reference, never ranked

Facts as published, dated. Uback does not rank or value Chinese companies and no intention can be declared on them.

  • Moon Biotech · ChinaStrain bank of more than 260,000 microorganisms (Apr 2025)Series C+ · USD 41.3M · Jul 2024

Listed benchmarks

Not ranked: no intention is possible on a listed company.

  • Biotalys · BelgiumEuronext Brussels · BTLS · about USD 105M (Oct 2026)
  • Bioceres Crop Solutions · ArgentinaNasdaq · BIOX · about USD 22M (Oct 2026)
  • Vittia · BrazilB3 · VITT3 · about USD 90M (Sep 2026)

Sources and method for this segment

Calendar. Global segment rankings are published twice a year. Next edition: February 12, 2027.

Eligibility. At least $1M raised in equity, non-listed company, main activity in this segment (biological inputs). A company appears in one segment only.

Sources. Company announcements, AgFunder News, Global AgInvesting, AgNavigator, AgFeed, Business Wire, CFNews, Tech.eu, The Packer, Fertilizer Daily, company filings and market data for listed companies.

Method and rules, common to all rankings →